InvestorsHub Logo
Followers 1
Posts 236
Boards Moderated 0
Alias Born 09/24/2013

Re: new_guy78 post# 10544

Saturday, 01/13/2018 1:10:28 PM

Saturday, January 13, 2018 1:10:28 PM

Post# of 12606
I own shares of BICX and am not trying to rain on anyone's parade. However I really don't think that it's a slam dunk quite yet. If I am not mistaken the meeting with the FDA is a pre-IND meeting. Does anyone know what can be determined at such a meeting? What if the FDA wants a p3 trial to absolutely determine the efficacy of the method of delivery of naletrexone? What if the FDA needs a double blind placebo controled study? What if the FDA wants to see the protocal of such a study?

The compound is approved by the FDA but as far as I can determine the method of delivery is not. If I am not mistaken that is the reason that BICX has difficulty getting insurance companies to pay for the procedure.

Perhaps someone on this board has answers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News